RAC 1.20% $1.68 race oncology ltd

RAC - Charts & Price Action, page-11309

  1. 5,713 Posts.
    lightbulb Created with Sketch. 1319
    RAC is well undervalued don't even put what RAC has done since buying (bisantrene)
    With testing that has been done before RAC took over we should be around $4 mark.
    Then you have to add all that has been done from when RAC took over.
    And more importantly the timeline we have saved by testing that has been done before we even bought Zantrene® (bisantrene).
    I am still very bullish that we will get to $30 mark sometime in the next year or 2 MAX.
    bought out.
    Yes there is risk but each announcement that comes out lowers that risk.
    Can't help the world is very volatile at the moment but when that right announcement comes out market will catch up.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.68
Change
0.020(1.20%)
Mkt cap ! $286.2M
Open High Low Value Volume
$1.68 $1.68 $1.61 $177.8K 108.9K

Buyers (Bids)

No. Vol. Price($)
1 1100 $1.64
 

Sellers (Offers)

Price($) Vol. No.
$1.68 4999 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.